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Background: synGAP inactivates Ras and Rap at synapses.
Results:Phosphorylation of synGAPbyCaMKII increases Rap1GAP activitymore thanHRasGAP activity; phosphorylation by
CDK5 has the opposite effect.
Conclusion: Phosphorylation by CaMKII and CDK5 alters the ratio of Rap1 and HRas GAP activities.
Significance:Phosphorylation of synGAPbyCaMKII andCDK5 can alter the balance of synaptic functions regulated byRas and
Rap.
synGAP is a neuron-specific Ras and Rap GTPase-activating
protein (GAP) found in high concentrations in the postsynaptic
density (PSD) fraction from themammalian forebrain.We have
previously shown that, in situ in the PSD fraction or in recom-
binant form in Sf9 cell membranes, synGAP is phosphorylated
by Ca2/calmodulin-dependent protein kinase II (CaMKII),
another prominent component of the PSD. Here, we show that
recombinant synGAP (r-synGAP), lacking 102 residues at the N
terminus, can be purified in soluble form and is phosphorylated
by cyclin-dependent kinase 5 (CDK5) as well as by CaMKII.
Phosphorylation of r-synGAP by CaMKII increases its HRas
GAP activity by 25% and its Rap1 GAP activity by 76%. Con-
versely, phosphorylation by CDK5 increases r-synGAP’s HRas
GAP activity by 98% and its Rap1 GAP activity by 20%. Thus,
phosphorylation by both kinases increases synGAP activity;
CaMKII shifts the relative GAP activity toward inactivation of
Rap1, and CDK5 shifts the relative activity toward inactivation
ofHRas. GAP activity towardRap2 is not altered by phosphoryl-
ation by either kinase. CDK5 phosphorylates synGAP primarily
at two sites, Ser-773 and Ser-802. Phosphorylation at Ser-773
inhibits r-synGAP activity, and phosphorylation at Ser-802
increases it. However, the net effect of concurrent phosphor-
ylation of both sites, Ser-773 and Ser-802, is an increase in GAP
activity. synGAP is phosphorylated at Ser-773 and Ser-802 in
the PSD fraction, and its phosphorylation byCDK5 andCaMKII
is differentially regulated by activation of NMDA-type gluta-
mate receptors in cultured neurons.
The PSD5 contains cytosolic signaling complexes associated
with glutamate receptors at the postsynaptic membrane of
excitatory synapses. synGAP, a dual Ras and Rap GAP, is abun-
dant in the PSDof excitatory synapses (1, 2). The family of small
GTPases, including Ras and Rap, act as effectors of a wide vari-
ety of signaling proteins, including several located in neuronal
synapses and dendrites (3). They adopt an active conformation
when bound to GTP and are inactivated when they hydrolyze
the bound GTP to GDP. GAP proteins, including synGAP,
increase the rate of inactivation of small GTPases by binding to
them and accelerating the rate at which GTP is hydrolyzed.
The GAP domain of synGAP is homologous to that of
p120GAP and neurofibromin, two canonical rasGAPs that do
not regulate Rap (1, 2, 4). Nevertheless, synGAP has been
shown to stimulate the GTPase activity of Rap about 100 times
more potently than that of Ras (5, 6). Pena et al. (6) found that
the upstream C2 domain of synGAP works with the GAP
domain to enable acceleration of Rap GTPase activity. synGAP
is the only example of a RapGAP that requires a second domain
in addition to the GAP domain for its catalytic activity.
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synGAP is tightly associated with the postsynaptic plasma
membrane and binds to the PSD-95, Discs-large, ZO1 (PDZ)
domains of PSD-95 (1, 2), which positions it in close proximity
to the NMDA-type and AMPA-type glutamate receptors
(NMDARs and AMPARs), respectively. Loss of one copy of the
synGAP gene produces cognitive dysfunction in mice (7) and
humans (8), indicating that the functions of synGAP are criti-
cally important for normal synaptic regulation. Influx of Ca2
through NMDARs and binding of ligands to TrkB (BDNF/neu-
rotrophin-3 growth factors receptor B) receptors can activate
Ras and Rap postsynaptically (3, 9, 10). Over time, Ras and Rap
modulate synaptic strength in opposite directions. Active Ras
increases insertion (exocytosis) of AMPARs at the synapse,
whereas active Rap increases their removal (endocytosis) from
the synapse (10). Here, we investigated whether phosphoryla-
tion of individual residues on synGAP could alter the ratio of its
Ras and Rap GAP activities such that the balance of these two
activities, and thus the balance of active Ras and Rap, could be
changed under different physiological conditions.
We previously showed that activation of NMDARs on cul-
tured CNS neurons leads to phosphorylation of synGAP by
CaMKII (1, 9, 11), and we identified several major sites on par-
tially purified, membrane-bound synGAP where phosphoryla-
tion by CaMKII increases its Ras GAP activity (11). Here we
show, with purified and soluble recombinant synGAP lacking
the first 102 N-terminal residues (r-synGAP), that phosphory-
lation byCaMKII increases itsHRas andRap1GAP activities by
25 and 76%, respectively, but does not affect its Rap2 GAP
activity.
We also show that r-synGAP is a substrate for CDK5, which
phosphorylates it at two sites, Ser-773/Thr-775 and Ser-802.
CDK5 is a proline-directed serine/threonine kinase that is
involved in many neuronal processes, including regulation of
synaptic plasticity (12–14). It is localized at synapses and inter-
acts with or regulates synaptic proteins, including NR2A (15),
PSD-95 (16), and CaMKII (17).
We found that phosphorylation of r-synGAP by CDK5
increases its HRas and Rap1 GAP activities by 98 and 20%,
respectively. Thus, phosphorylation of synGAP by CaMKII
accelerates the rate of inactivation of Rap1 more potently than
the rate of inactivation of HRas, whereas phosphorylation by
CDK5 has the opposite effect. We show that Ser-773 and Ser-
802 are both phosphorylated in amouse PSD fraction. Further-
more, phosphorylation by the two kinases is dynamically regu-
lated by NMDA receptors in cultured neurons. These results
mean that differential phosphorylation of synGAP by CaMKII
andCDK5may alter the proportions of activatedRas andRap in
synapses with consequent effects on cellular processes regu-
lated by the two GTPases.
EXPERIMENTAL PROCEDURES
Cloning, Expression, and Purification of r-synGAP—Soluble
recombinant synGAP comprising residues 103–1293 (r-syn-
GAP) was purified from Escherichia coli. Pena et al. (6) had
previously shown that removal of the N-terminal 102 residues
and several hundred residues from the C terminus enabled
purification of a soluble active fragment of synGAP comprising
residues 103–725 (sr-synGAP). Gene fragments encoding rat
r-synGAP and sr-synGAP (AF048976) were amplified by PCR
with PfuUltra II fusion HS (Agilent, catalog no. 600670) and
cloned by the polymerase incomplete primer extension-liga-
tion-independent cloning method (18, 19) into pET-47b()
(EMDMillipore, catalog no. 71461) in-frame with an N-termi-
nal His6 tag and a PreScission protease cleavage site. The DNA
sequence was verified by Sanger sequencing (Laragen). The
plasmidswere transformed into theRosetta2(DE3)E. coli strain
(EMDMillipore, catalog no. 71397) for protein expression. Sin-
gle colonies were grown overnight at 37 °C in 5 ml of Miller
lysogeny broth (LB; EMD Millipore, catalog no. 71753-6) sup-
plemented with 50 g/ml kanamycin and 34 g/ml chloram-
phenicol. Cultures grown overnight were diluted 1:500 into LB
and grown at 37 °C for 4–6 h to an A600 of 1.0. Cultures were
then chilled to 18 °C, and protein expression was induced with
0.2 mM isopropyl 1-thio--D-galactopyranoside for 24 h. Bac-
terial pellets were harvested by centrifugation and resuspended
in Lysis/Wash Buffer (20 mM Tris, 500 mMNaCl, 10 mM tris(2-
carboxyethyl)phosphine (TCEP; Gold Biotechnology, catalog
no. TCEP25), 5 mMMgCl2, 60 mM imidazole, 2 mM ATP, 1 mM
PMSF (Sigma, catalog no. P76726), 0.2% TergitolTM-type Non-
idet P-40, and Complete EDTA-free protease inhibitor (Roche
Applied Science, catalog no. 5056489001), pH 7.0) supple-
mented with 25 units/ml benzonase (EMD Millipore, catalog
no. 71206) and 10 kilounits/ml ReadyLyse (Epicenter, catalog
no. R1810M). Cells were lysed with an ML-110 microfluidizer
(Microfluidics), and insolublematerial was removed by centrif-
ugation at 30,000 g. r-synGAP in the supernatant was bound
to 1.5 ml of Talon metal affinity resin per g of cell pellet (Clon-
tech, catalog no. 635503) by batch absorption for 90 min. The
resin was poured into a gravity-fed column and washed with 10
column volumes of Lysis/Wash Buffer. r-synGAP was eluted
with Lysis/Wash Buffer (2 mM ATP) supplemented with 10
mM EDTA and 250 mM imidazole. Fractions containing syn-
GAPwere pooled and concentrated by ultrafiltration through a
150-kDa cutoff filter (Thermo Scientific, catalog no. 89923) for
r-synGAP, and a 9-kDa cutoff filter (Thermo Scientific, catalog
no. 89885A) for sr-synGAP. The presence of 0.2% TergitolTM
was necessary to prevent loss of synGAP on the filter. Concen-
trated samples of r-synGAP (0.25–1 mg/ml) were then
exchanged into Storage Buffer by ultrafiltration (20 mM Tris,
500 mM NaCl, 10 mM TCEP, 5 mM MgCl2, 1 mM PMSF, 0.2%
TergitolTM-type Nonidet P-40, and Complete EDTA-free pro-
tease inhibitor, pH 7.0), flash-frozen in liquid nitrogen, and
stored at 80 °C. Concentrated samples of sr-synGAP were
further purified on a HiLoad 26/600 Superdex 200 preparation
grade column (GE Healthcare, catalog no. 28-9893-36) equili-
brated with Storage Buffer. Fractions containing sr-synGAP
were pooled, concentrated by ultrafiltration to 2 mg/ml, flash-
frozen in liquid nitrogen, and stored at 80 °C. All mutant
forms of r-synGAP were purified by the same procedure as for
wild type r-synGAP.
Cloning, Expression, and Purification of HRas, Rap1, and
Rap2—Gene fragments coding for full-length rat HRas
(AAA42009.1), human Rap1B (CAB46488), and human Rap2A
(CAA31052.1) were amplified by PCR and inserted into pGEX-
6P-1 expression vectors (GE Healthcare, catalog no. 28-9546-
48) at a site bound by EcoRI and XhoI recognition sites and
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in-frame with an N-terminal GST tag and a PreScission Prote-
ase cleavage site. The sequence of each plasmid was verified,
and they were transformed into Rosetta2 E. coli cells (EMD
Millipore, catalog no. 71402-4) for protein expression. Single
colonies were grown overnight at 37 °C in 5 ml of LB supple-
mented with 100 g/ml carbenicillin and 34 g/ml chloram-
phenicol.Overnight cultureswere diluted 1:500 into LB supple-
mented with 2% glucose and grown at 37 °C for 4–6 h to an
A600 of 1.0. Cultures were then chilled to 22 °C, and protein
expression was induced with 0.1 mM isopropyl 1-thio--D-
galactopyranoside for 4 h. Bacterial pellets were harvested by
centrifugation, resuspended in GTPase Lysis/Wash Buffer (50
mMTris, 100mMNaCl, 5mMTCEP, 5mMMgCl2, 1mMEDTA,
1 mM PMSF, 30 M GDP, 0.1% Triton X-100, Complete prote-
ase inhibitor, pH 7.5) supplemented with 25 units/ml benzo-
nase, and 10 kilounits/ml ReadyLyse, and lysed by fluidization.
Insolublematerial was removed by centrifugation at 30,000 g.
The expressed protein in the supernatant was bound to 0.3 ml
of glutathione-agarose resin per g of cell pellet (Thermo Scien-
tific, catalog no. 16100) by batch absorption for 3 h. The resin
was poured into a gravity-fed column and washed with 20 col-
umn volumesGTPase Lysis/Wash Buffer. GTPases were eluted
with Cleavage Buffer (50mMTris, 100mMNaCl, 5 mMTCEP, 5
mM MgCl2, 1 mM EDTA, 30 M GDP, 0.1% Triton X-100, and
50 mM glutathione, pH 8.0). Fractions containing the GTPases
were pooled and concentrated by ultrafiltration through a
9-kDa cutoff filter. Concentrated samples of GTPase were
mixed with 20 units/ml PreScission Protease (GE Healthcare,
catalog no. 27-0843-01) and cleaved for 18 h at 4 °C to release
GST. Samples were exchanged into SEC Buffer (20 mM Tris,
100 mM NaCl, 5 mM TCEP, 5 mM MgCl2, 1 mM PMSF, 30 M
GDP, and10%glycerol, pH8.0) andconcentratedbyultrafiltration
before being fractionated on aHiLoad 26/600 Superdex 75 prepa-
ration grade column (GE Healthcare, catalog no. 28-9893-33)
equilibrated with SEC buffer. Fractions containing GTPases were
pooled, concentrated by ultrafiltration to greater than 1 mg/ml,
flash-frozen in liquid nitrogen, and stored at80 °C.After SEC,
all three GTPases were purified to 95% purity, with yields of
25%. The intrinsic kcat values of purified GTPases, measured
in our assay, were 0.0008, 0.0001, and 0.00008 s1, for HRas,
Rap1, and Rap2, respectively.
SDS-PAGE and Assessment of Protein Purity and Yield—We
used SDS-PAGE to determine the purity of proteins and to
quantify yields throughout the purification process. Protein
samples were diluted 1:4 into 4 LDS buffer (catalog no.
NP0007) and heated to 70 °C for 10min before fractionation on
NuPAGE Novex 4–12% BisTris SDS-polyacrylamide gradient
gels (catalog no. NP0336PK2) run under reducing conditions
with NuPAGE antioxidant (catalog no. NP0005) and MOPS
running buffer (catalog no. NP0001–02), all purchased from
Life Technologies. Proteins were stained with Gel Code Blue
(Thermo Scientific, catalog no. 24592), imaged on a Li-Cor
Odyssey Classic Infrared Imaging System (Li-Cor Biosciences)
at 700 nm, and quantified with LiCor Image Studio Software
(version 4.0.21) against standard curves of bovine serum albu-
min (BSA, catalog no. A7517-1VL), lysozyme (catalog no.
L4631-1VL), or LacZ (catalog no. G8511-1VL), all purchased
fromSigma. The protein standardswere loaded onto each gel in
lanes adjacent to the protein samples. Molecular weights of
stained proteins were verified by comparison with Precision
Plus Protein All Blue Standards (Bio-Rad, catalog no.
161-0373).
Site-directed Mutagenesis of CDK5 Phosphorylation Sites in
r-synGAP—Ten r-synGAPmutants were prepared to study the
effects of specific CDK5 phosphorylation sites on synGAP
activity. They included singlemutations S773A, T775A, S802A,
S773D, T775D, and S802D; double mutations S773A/T775A,
S773D/T775D, and S773D/S802D; and the triple mutation
S773A/T775A/S802A. Oligonucleotides encoding these muta-
tions were designedwith theQuikChange II primer design pro-
gram (Agilent) and were synthesized by Integrated DNATech-
nologies (IDT). Mutations of synGAP were made with the
QuikChange II XL site-directed mutagenesis kit (Agilent, cata-
log no. 200522).
Site-directed Mutagenesis of CaMKII Phosphorylation Sites
in r-synGAP—A mutant r-synGAP (CTM-Plus) was con-
structed based on the CTM-mutant, published earlier (11), by
adding mutations of newly identified CaMKII phosphorylation
sites to determine their effects on synGAP activity. Serine and
threonine residues at sites 750, 751, 756, 764, 765, 1058, 1062,
1064, 1093, 1095, 1099, 1123, and 1125 in synGAP were all
replaced with alanine residues. A pair of complementary oligo-
nucleotides encoding serine to alanine mutations of 750, 751,
756, 764, and 765 was designed with DNA2.0 Gene Designer
(version 1.1.4) (DNA2.0) and IDTOligo Analyzer software and
synthesized by IDT. Mutagenesis of r-synGAP was performed
with a QuikChange II XL site-directed mutagenesis kit, as
described previously (20), to generate the CTM-half. Next, a
pair of large oligonucleotides encoding mutations to alanine at
sites 1058, 1062, 1064, 1093, 1095, 1099, 1123, and 1125 was
designed and synthesized as described above. The second oli-
gonucleotide pair was inserted into the CTM-half cDNA by the
polymerase incomplete primer extension-ligation-indepen-
dent cloningmethod (18, 19) to generate the CTM-Plus cDNA.
CTM-Plus was transformed into One-shot TOP10 chemically
competent cells (Life Technologies, catalog no. C4040-06) for
propagation, and the DNA sequence was verified.
Stoichiometry and Rate of r-synGAP Phosphorylation by
CaMKII andCDK5—Phosphorylation of r-synGAP byCaMKII
(purified as described in Ref. 21) or by CDK5/p35 (EMDMilli-
pore, catalog no. 14-477M) was carried out in a 250-l reaction
mixture containing 50 mM Tris-HCl, pH 8.0, 10 mM MgCl2, 0
(CDK5) or 0.7 mM (CaMKII) CaCl2, 0.4 mM EGTA, 30 or 500
M (as indicated) [-32P]ATP (100–375 cpm/pmol), 0 (CDK5)
or 3.375 M (CaMKII) calmodulin, 10 mM DTT, 286 nM r-syn-
GAP, and 3.1 nM rat brain CaMKII or 110 nM CDK5/p35. Car-
rier-free -labeled ATP (6000 Ci/mmol, PerkinElmer Life Sci-
ences, catalog no. BLU002Z/NEG002Z) was diluted to the
desired specific activity by addition of unlabeled ATP (Sigma,
catalog no. A2383-25G). Phosphorylationwas initiated by addi-
tion of ATP to a reaction mixture prewarmed to 30 °C. At the
indicated time points, reaction aliquots were removed and
quenched by the addition of 0.25 volume of ice-cold 4 LDS
Sample Buffer containing 10% -mercaptoethanol. Samples
were fractionated by SDS-PAGE as described above. Gels were
rinsed in water, wrapped in SaranWrap, and exposed to a Stor-
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age Phosphor screen (GE Healthcare, catalog no. 63-0034-79)
for 2–4 h to locate phosphorylated proteins. To quantify the
amount of phosphate incorporated, the density of 32P bands
was determined by scanning with a Typhoon LA 9000 Phos-
phorImager (GE Healthcare) followed by analysis with Image-
Quant TL software (GEHealthcare, catalog no. 29000737). Rel-
ative densities were converted to picomoles of phosphate
by comparison with densities from standard amounts of
[-32P]ATP spotted onto filter paper and imaged simultane-
ously. The stoichiometry of phosphorylation was calculated by
dividing the picomoles of incorporated phosphate by the
amount of synGAP (3.8 pmol) loaded per lane.
Confirmation of r-synGAP Phosphorylation by CaMKII or
CDK5/p35 by Western Blotting—For Western blotting, phos-
phorylation of r-synGAP was carried out, as described above,
except with 30 or 500 M cold ATP in place of [-32P]ATP.
After SDS-PAGE, proteins were electrically transferred to
PVDF membranes (Thermo Scientific, catalog no. 8520) in 25
mMTris, 200 mM glycine, and 20%methanol. Membranes were
washed with 50 mM Tris-HCl, 150 mM NaCl, pH 7.6 (TBS),
followed by blockingwithOdyssey BlockingBuffer (Li-Cor Bio-
sciences, catalog no. 927-40003). Membranes were washed in
TBS supplemented with 0.1% Tween before incubation in
Odyssey Blocking Buffer or 5% Fraction V BSA (Sigma, catalog
no. A9418-100G) in TBS (phosphosite antibodies only) con-
taining one or more of the following dilutions of primary anti-
bodies: 1:2000 mouse anti-bovine serum albumin (Abcam,
catalog no. ab3781, RRID, AB_304073); 1:2000 rabbit anti-
phospho-synGAP-Ser-1123 (MBK Laboratory; see Ref. 11);
1:2000 rabbit anti-phospho-synGAP-Ser-764/5 (MBK Labora-
tory; see Ref. 11); 1:1000 rabbit anti-synGAP (Thermo Scien-
tific, catalog no. PA1-046, RRID, AB_2287112); 1:500 rabbit
anti-pSer CDK substrate (Cell Signaling Technology, catalog
no. 2324S, RRID, AB_2244779 (discontinued, replacement cat-
alog no. 9477)); and 1:1000 mouse BSA-free anti-Tetra-His
(Qiagen, catalog no. 34670). Bound antibodies were detected
with 1:10,000 donkey anti-rabbit IRdye700 (Rockland Immu-
nochemicals, catalog no. 610-731-124, RRID, AB_220145) or
goat anti-rabbit IRdye800 (Rockland Immunochemicals, cata-
log no. 611-132-002, RRID,AB_1660971), or 1:10,000 goat anti-
mouseAlexa-Fluor 680 (Life Technologies, catalog no. A21057,
RRID, AB _10562421), visualizedwith a Li-CorOdyssey Classic
Infrared Imaging System and quantified with the Li-Cor Image
Studio software (version 4.0.21).
GTPase Assays—The GTPases were loaded with [-32P]GTP
by nucleotide exchange as described previously (15, 22, 23).
HRas, Rap1, or Rap2 (200 M) were first incubated in 25 mM
Tris, pH 8.0, 100 mM NaCl, 5 mM DTT, 15 mM EDTA, 100 mM
NH4SO4, and 10mMGTP for 60min at room temperature. The
exchange reactions were terminated by the addition of 25 mM
MgCl2. GTPases were concentrated and separated from
unbound nucleotides and EDTA by ultrafiltration at 4 °C in an
Amicon concentrator (EMD Millipore, catalog no. UFC501096).
GTPases were then loaded with [-32P]GTP by incubating
GTP-boundGTPase (0.8 or 1.6mM) with 10Ci of [-32P]GTP
(6000 Ci/mmol; PerkinElmer Life Sciences, catalog no.
BLU004Z/NEG004Z) in the presence of 12 mM EDTA for 40
min on ice. The exchange reaction was terminated by addition
of 25 mM MgCl2. [-32P]GTP-bound HRas or Rap GTPases
were diluted to the desired concentration before use in GTPase
assays.
The GTPases pre-loaded in this way undergo one round of
hydrolysis of the bound GTP at fixed, slow intrinsic rates as
follows:4–8 104 s1 (Ras) and0.5–1 104 s1 (Rap1
and -2). When synGAP is added to an assay under these condi-
tions, it acts as a catalyst, accelerating the rate of the single
hydrolysis reactions. The acceleration of hydrolysis of GTP by
HRas, Rap1, or Rap2 by synGAP was assayed by measuring the
rate of release of [-32P]phosphate as described previously (24).
Briefly, phosphorylated or nonphosphorylated synGAP (250–
500 nM) was mixed with increasing concentrations of each
GTPase bound to radioactive [-32P]GTP at 25 °C in 6.5 l of
Assay Buffer (25 mM Tris, pH 8.0, 100 mMNaCl, 15 mMMgCl2,
and 5 mM DTT) as described previously (15). After 10 min, the
assaywas quenchedwith activated charcoal in phosphate buffer
to adsorb proteins GTP and GDP. Following removal of the
charcoal, free [-32P]phosphate was quantified by scintillation
counting in Beta Blend scintillant (MP Biomedicals, catalog no.
0188245001). Initial rates of GTP hydrolysis for each concen-
tration of GTPase with and without synGAP were determined
after fitting the data by linear regression. The rates were plotted
against the corresponding concentrations of GTPase with
Prism software (version 6.0d, GraphPad Software, La Jolla, CA),
and the data were fit to a hyperbolic curve by nonlinear regres-
sion. TheMichaelis-Menten equationwas used to calculate kcat
and Km values.
Phosphorylation of r-synGAP by CaMKII or CDK5/p35 for
Use in GAPAssays—Phosphorylation of synGAP by CaMKII or
CDK5/p35 was carried out immediately prior to GAP assays in
reaction mixtures containing 50 mM Tris-HCl, pH 8.0, 10 mM
MgCl2, 0 (CDK5) or 0.7mM (CaMKII) CaCl2, 0.4mM EGTA, 30
M ATP, 0 (CDK5), or 3.375 M (CaMKII) calmodulin, 10 mM
DTT, 725 nM r-synGAP, and 10 nM rat brain CaMKII or 230 nM
CDK5/p35. Phosphorylation was initiated by addition of ATP
to reactionmixtures prewarmed to 30 °C. At the indicated time
points, aliquots were removed from the reaction and quenched
by the addition of 1⁄3 volume of ice-cold Kinase Quench Buffer
(20 mM Tris-HCl, pH 8.0, 396 mM NaCl, 2 mM DTT, 30 mM
EGTA, 0.2% TergitolTM-type Nonidet P-40, 90 M roscovitine
(Sigma, catalog no. R7772-5MG) and 6 M auto-camtide 2-re-
lated inhibitory peptide (Sigma, catalog no. A4308)). Samples
were stored on ice until their addition to GAP assays.
Mass Spectrometry of Phosphorylated r-synGAP—Mass spec-
trometry of r-synGAP was performed by the Proteome Explo-
ration Laboratory at the California Institute of Technology.
r-synGAPwas phosphorylated for 2 and 10min in the presence
of 30 M ATP as described above, except with unlabeled ATP.
All liquid chromatography-mass spectrometry (LC-MS) exper-
iments were performed on an EASY-nLC (Proxeon Biosystems,
now Thermo Scientific) connected to a hybrid LTQ-FT
(Thermo Scientific) equipped with a nano-electrospray ion
source (Proxeon Biosystems, now Thermo Scientific) essen-
tially as described previously (25), with the modifications indi-
cated below. Peptides were separated on a 15-cm reverse phase
analytical column (75 m inner diameter) packed in-house
with 3 m ReproSil-Pur C18AQ beads (Dr. Maisch GmbH,
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catalog no. r13.aq.) with a 60-min gradient at a flow rate of 350
nl/min. The gradient was run from 0 to 40% solvent B (97.8%
acetonitrile, 0.2% formic acid, 2%water) in 40min, increased to
100% B in 1 min, and run at 100% B for 19 min. The mass
spectrometer was operated in data-dependent mode to auto-
matically switch between full scan MS and MS2 acquisition.
Survey full scan mass spectra were acquired in ion cyclotron
resonance, over a range of 400–1800m/z, following accumula-
tion of 1,000,000 ions, with a resolution of 100,000 at 400m/z.
The top five most intense ions from each survey scan were
isolated and, after the accumulation of 5000 ions, fragmented in
the linear ion trap by collision-induced dissociation (collisional
energy 35% and isolation width 2 Da). Additionally, an MS3
neutral loss scan was acquired to detect loss of phosphoric acid
(32.67, 49.00, or 97.97m/z) in the top fivemost intense peaks in
theMS2. Precursor ion charge state screening was enabled, and
all singly charged and unassigned charge states were rejected.
The dynamic exclusion list was set with a maximum retention
time of 90 s and a relative mass window of 10 ppm, and early
expiration was enabled.
Tandem mass spectra were converted to mgf files with the
use of ReAdW4Mascot2 (peptide.nist.gov/metrics). MS3 spec-
trawere separated fromMS2 spectra, and accuratemasseswere
determined forMS3 precursor spectra by the method of Timm
et al. (26). All MS/MS samples were analyzed with the use of
Mascot (version 2.2.06, MatrixScience). We constructed a
sequence database containing the sequence of synGAP and
common contaminants, including keratins and trypsin (262
entries). Trypsin was specified as the digestion enzyme, and up
to two missed cleavages were allowed. We set mass tolerances
of 10 ppm for parent ions and 0.50 Da for fragment ions. Carb-
amidomethylation of cysteine (57.0215 Da) was specified in
Mascot as a fixed modification, and oxidation of methionine
(15.9949Da), dehydration of serine and threonine (18.0106
Da, only MS3 spectra), and phosphorylation of serine, threo-
nine, and tyrosine (79.9663 Da, onlyMS2 spectra) were spec-
ified as variable modifications. Mascot results were loaded into
Scaffold (version 3.00.06, Proteome software) and filtered at a
protein probability of 99%with aminimumof two peptides and
a peptide probability of 95%. We calculated false localization
rates of phosphorylation sites using the Mascot Delta-score as
described by Savitski et al. (27). In this algorithm, peptides with
only one possible phosphorylation site are given a false localiza-
tion rate of zero. Summaries of data and annotated spectra for
all phosphorylation sites are included in the supplemental
material.
Detection of Phosphorylated Ser-773 and Ser-802 in the PSD
Fraction byMass Spectrometry—Aliquots of PSD fraction from
mice (65–125g), prepared as described below,were incubated
with 0 or 30 M ATP for 10 min in 120 l of the reaction mix
described above. In some experiments, exogenous CDK5/p35
(1–2 units) and/or 100 M roscovitine (Sigma, catalog no.
R7772-5MG) were added. Proteins were fractionated by SDS-
PAGE and stained with Gel Code Blue, and the 140–160-kDa
bands containing synGAPwere excised and digested with tryp-
sin in the gel as described previously (28). synGAP samples
were analyzed on an Orbitrap Fusion (Thermo Scientific)
equipped with a nano-electrospray ion source coupled to an
EASY-nLC. Peptides were separated on a 25-cm reverse phase
analytical column (75 m inner diameter) packed in-house
with 3mReproSil-Pur C18AQ beads with a 100-min gradient
at a flow rate of 350 nl/min. The gradient ran from 2% solvent B
(80% acetonitrile, 0.2% formic acid, 19.8%water) to 40% solvent
B in 90 min, then increased to 100% in 1 min, and held at 100%
for 9 min. A parallel reaction-monitoring strategy (29) was
employed to monitor the levels of phosphorylation on synGAP
at sites Ser-773 and Ser-802. Precursor ions were isolated in the
quadrupole, fragmented by HCD, and sent to the Orbitrap
measurement (isolation width 1 Da, normalized collision
energy of 35%, AGC target of 100,000 ions with a maximum
injection time of 50ms). The peptidesmonitored for phosphor-
ylation at site Ser-773 included LPSPTK (m/z 361.6779, z 2),
GLNSSMDMARLPSPTK (m/z 595.6072, z  3), GLNSSMD-
MARLPSPTK (m/z 606.2705, z  3), and LPSPTKEKP-
PPPPPGGGK (m/z 620.9922, z 3). The peptidemonitored for
phosphorylation at site Ser-802 was SSPAYCTSSSDITEPEQK
(m/z 1033.9166, z 2). Special cautionwas taken to identify the
correct chromatographic peak based on fragment ions unique
to phosphorylation at Ser-802 and not Tyr-805, Thr-807, Ser-
808, Ser-809, or Ser-180. Three additional nonmodified pep-
tides from synGAP were used to control for loading amounts.
These peptides included VIQNLANFSK (m/z 567.3193, z 2),
SASGDTVFWGEHFEFNNLPAVR (m/z 827.3925, z  3), and
EFAEYVTNHYR (m/z 714.8308, z  2). Raw data were
imported into Skyline (30) formanual validation and extraction
of peak areas. Statistical analysis of the variation in phosphory-
lation levels was carried out using MSstats (31).
Preparation of the PSD Fraction fromMouse Forebrain—The
PSD fraction was prepared as described previously (32) by a
modification of the method of Carlin et al. (33). We have been
unable to extract synGAP from the PSD fraction without
destroying its GAP activity.
Immunoprecipitation fromMouse BrainMembrane Fraction—
Forebrains from adultmalemice were homogenizedwith 12 up
and down strokes at 900 rpm. The homogenate was cleared of
membrane and nuclei by centrifuging at 1000  g for 10 min.
The supernatant was centrifuged at 100,000 g for 1 h, and the
pellet was solubilized in 1% deoxycholate. The solubilized frac-
tion was brought to 50 mM Tris, pH 7.4, 150 mM NaCl, 1%
Triton X-100, 1 Roche Applied Science protease inhibitor
tablet, 0.2% deoxycholate, and the protein concentration was
determined by the bicinchoninic acid method (Thermo Scien-
tific, catalog no. 23225)with BSA as the standard. Anti-synGAP
Ab (Thermo Scientific, catalog no. PA1-046, RRID, AB_
2287112) or anti-rabbit IgG isotype control Ab (Upstate) (8g)
in a final volume of 300l in 100mM sodium citrate, pH 5, 0.1%
Tween 20 was precoupled with 25 l of protein G-magnetic
Dynabeads (Invitrogen, catalog no. 10004D) at 4 °C overnight
with end-over-endmixing. The beads were washed with 500l
of 100mM sodium citrate, pH 5, 0.1% Tween 20, three times for
5 min each before incubating with 1.5 mg of protein for 3 h at
4 °C. The immunoprecipitates were washed four times with 50
mM Tris, pH 7.4, 150 mM NaCl, 0.1% Triton X-100 before pro-
teins were eluted with 1 SDS loading buffer. Samples were
fractionated by SDS-PAGE on a 6% gel, and immunoblots were
prepared as described above. The gel was run long enough to
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ensure separation of the three major splice variants of synGAP.
Immunoblots were probed with -phospho-CDK5 substrate
(1:500; Cell Signaling Technology, catalog no. 2324S, RRID,
AB_2244779 (discontinued, replacement catalog no. 9477)),
-total synGAP (1:2000, Thermo Scientific, catalog no. PA1-
046, RRID,AB_2287112),-PSD-95 (1:1000, ThermoScientific
Pierce Products, catalog no. MA1-046, RRID, AB_2092361),
and -GluR2 (1:1000, EMD Millipore catalog no. MAB397,
RRID, AB_2113875).
Preparation and Treatment of Cortical Neuronal Cultures—
Cultures of cortical neurons were prepared from fetal mice as
described previously (9, 34). After 4 days in vitro cultures were
treated with 5 M cytosine arabinoside (Sigma, catalog no.
C6645) to halt the growth of non-neuronal cells. For treat-
ments, cultures (days in vitro 13–14) were washed in HEPES/
control salt solution (HCSS: 20mMHEPES, 120mMNaCl, 5mM
KCl, 5.5 mM glucose, 0.8 mM MgCl2, pH 7.4) and then exposed
to 25 M NMDA (Tocris, catalog no. 114) dissolved in HCSS
(2–4 wells for each condition) for 0, 0.25, 1, 3, and 5 min. In
some experiments, cultures were pretreated prior to exposure
to NMDA with 30 M roscovitine (Sigma, catalog no. R7772-
5MG), 5 M cyclosporin A (inhibits calcineurin; Sigma catalog
no. 30024), 1 M okadaic acid (inhibits PP2A strongly and PP1
weakly at this concentration; EMD, catalog no. 459620), or 500
nM tautomycin (inhibits PP1; EMD catalog no. 580551), as
stated. For experiments in which CDK5 activity was inhibited
with roscovitine, control wells were treated with an equal
amount of vehicle (DMSO at 0.12%). After treatment, cells
were lysed, and protein concentrations were determined by the
bicinchoninic acid method with BSA as the protein standard.
Tomeasurephosphorylationof synGAP, 15–30gof cell lysate
was fractionated by SDS-PAGE, transferred to nitrocellulose
membranes, blocked, and incubated with primary antibodies as
described above. Antibodies included those listed above and
-MAP-2 (1:5000, Sigma catalog no. M4403). Bound antibodies
were detected with IRdye700- or IRdye800-conjugated secondary
antibody (Rockland Immunochemicals catalog no. 610-130-121,
RRID, AB_220121, and catalog no. 611-131-122, RRID, AB_
220150) and visualizedwith theOdyssey infrared imaging system.
Reported protein values were normalized either for staining for
total synGAP or forMAP-2, as stated.
RESULTS
Purification of r-synGAP—It was previously shown that a
shortened form of synGAP (sr-synGAP) comprising residues
103–725 can be expressed in soluble form inE. coli and that this
construct displaysGAP activity against Rapwith a potency sim-
ilar to other Rap-GAPs. In contrast, its GAP activity against Ras
is considerably less potent than that of other RasGAPs (6). sr-
synGAP includes the N-terminal pleckstrin homology, C2, and
RasGAP domains, but it lacks residues 726–1293 that contain
a predicted disordered domain containing the regulatory
CaMKII phosphorylation sites (11), a short predicted coiled coil
domain, and the C-terminal PDZ domain-binding motif (1, 2).
To enable study of the regulatory roles of phosphorylation of
purified synGAP by CaMKII and other protein kinases, we
FIGURE 1. Purification of heterologously expressed sr-synGAP and r-synGAP. Heterologously expressed sr-synGAP and r-synGAP were purified on Talon
metal affinity resin and Superdex 200 size exclusion resin as described under “Experimental Procedures.” A, His-tagged sr-synGAP; B, His-tagged r-synGAP.
Proteins in the indicated pools were fractionated on 4–12% gradient SDS-polyacrylamide gels and stained as described under “Experimental Procedures.” S,
soluble protein;U,unboundprotein; E, eluate fromTalonmetal affinity columns; X, eluate fromSuperdex 200 column.C,domainmapof synGAP; PH, pleckstrin
homology domain (103–203); C2 domain (229–392); RasGAP, Ras GTPase-activating protein domain (393–715); disordered domain (725–1145); CC, coiled-coil
domain (1146–1260); PDZ binding domain (1289–1293).
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expressed and purified a nearly full-length soluble synGAP
fragment (r-synGAP; residues 103–1293) (Fig. 1B). We also
purified sr-synGAP for comparison (Fig. 1A). We found that
both of these shortened forms of synGAP were soluble when
expressed in bacteria at low temperature (e.g. 18 °C), but they
required addition of ATP and Mg2 to release bound chaper-
one (GroEL) and to permit effective binding of the recombinant
protein to Talon metal affinity columns during purification
(data not shown). A combination of immobilized metal affinity
chromatography and SEC was used to purify the synGAP con-
structs as described under “Experimental Procedures.” sr-syn-
GAP was purified to95% purity, with typical yields in excess
of 75%. r-synGAP was purified by immobilized metal affinity
chromatography alone to70% purity, with yields in excess of
85%. r-synGAP eluted in the void volume of SEC columns with
no improvement in purity, suggesting that the presence of the
disordered domain and/or the coiled-coil domain may predis-
pose r-synGAP to multimerization. Fig. 1C is a domain map of
synGAP showing the boundaries of the two recombinant forms
and the positions of previously identified phosphorylation sites.
IntrinsicGAPActivityof r-synGAP—synGAPhasbeenshownto
stimulate the GTPase activity of Rap much more potently than
that of Ras (5, 6). sr-synGAP, containing the pleckstrin homology,
C2, and Ras GAP domains, was found to stimulate the intrinsic
GAP activity of Rap1 by 4 orders ofmagnitude, to a kcat of 0.8 s1,
and that of HRas by 2 orders of magnitude (6).
We attempted to measure the enzymatic constants for the
acceleration of GAP activity of HRas, Rap1, and Rap2 by limit-
ing amounts of r-synGAP or sr-synGAP (Fig. 2 and Table 1). In
our assay, both synGAP constructs stimulated the rate of GTP
hydrolysis by HRas by 2 orders of magnitude (Fig. 2A), consis-
tent with previous findings (6). Stimulation of GTPase activity
by sr-synGAP varied approximately linearly withHRas concen-
tration in the range that we were able to test (10–700 M).
Therefore, we were not able to estimate kcat or Km values. At
700MHRas, kobs in the presence of sr-synGAPwas 0.13 s1. In
FIGURE 2.GAP activity of sr-synGAP and r-synGAP.GTPase activities in the presence of sr-synGAP (left panels) and r-synGAP (right panels) weremeasured as
a function of GTPase concentration in the absence and presence of purified sr- or r-synGAP (350 nM) for 10 min at 25 °C as described under “Experimental
Procedures.” A,HRas (10–700M); B, Rap1 (15–400M); and C, Rap2 (15–400M). Data aremean S.E. (n 3–6 for r-synGAP and n 1–2 for sr-synGAP). The
kobs was calculated as moles of phosphate released per s/mol of synGAP when synGAP is present, and as moles of phosphate released per s/mol of GTPase
concentration in the absence of synGAP. Note that the concentration of synGAP is much less than that of the GTPases, so the increase in kobs with GTPase
concentration reflects increased binding of the GTPases to limiting synGAP. See Table 1 for estimates of kcat and Km.●,synGAP;Œ,synGAP.
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contrast, stimulation ofHRasGTPase by r-synGAP varied non-
linearly with HRas concentration and could be fit by a hyper-
bolic curve, permitting estimation of kcat 0.12 0.05 s1 and
Km  640  400 M. The error of these calculations is high;
thus, they can only be considered estimates.
Stimulation of GTPase activity of Rap1 by both sr-synGAP
and r-synGAP followed a hyperbolic curve with increasing
Rap1 concentrations (Fig. 2B). For sr-synGAP, we calculated
kcat  0.47  0.06 s1, which is in reasonable agreement with
the value of 0.8 s1 reported by Pena et al. (6), and Km 200
55 M. r-synGAP stimulated the GTPase activity of Rap1 to a
kcat of 3.8  1.1 s1, which is greater than the stimulation by
sr-syn-GAP. However, the affinity of r-synGAP for Rap1
appeared considerably lower (Km 1800 600 M) than that
of sr-synGAP. The fold stimulations of Rap1GTPase activity by
sr-synGAP and r-synGAP were 4300 and 35,000, respectively.
These results suggest that the carboxyl portion of r-synGAP
(residues 726–1293) alters the interaction of synGAP with
Rap1, producing a lower affinity, but a greater maximum stim-
ulation of its GTPase activity.
Stimulation of GTPase activity of Rap2 by sr-synGAP was
linear over the range of Rap2 concentrations we were able to
test (15–400 M), again precluding estimation of kcat and Km
values (Fig. 2C). r-synGAP stimulated Rap2 GTPase to approx-
imately the same rate as did sr-synGAP. However, for r-syn-
GAP, the plot of kobs against the Rap2 concentration was
slightly hyperbolic, permitting rough estimates of kcat 6.8
3 s1 and Km 3100 1500M. This represents a stimulation
of GTP hydrolysis in the presence of r-synGAP of87,000-fold
over the rate of hydrolysis by Rap2 alone (Table 1). Because we
could not calculate a kcat for sr-synGAP, it is not clear whether
the carboxyl-half of r-synGAP alters its interaction with Rap2
as it appears to with Rap1.
Our measured Km values are relatively high compared with
many other enzymes, indicating a relatively low affinity of syn-
GAP for the GTPases. However, other dual specificity GAPs
and Rap GAPs have Km values in the range of tens to a few
hundred micromolars (15, 22). A high Km value can be advan-
tageous because it permits a linear response of catalytic rate
over a wide range of substrate concentrations (35). The impor-
tance of this property in spine synapses is not clear because the
effective concentrations of activated Ras or Rap in the confined
space of the postsynaptic density after different in vivo stimuli
are not known.
Stoichiometry and Rate of r-synGAP Phosphorylation by
CDK5—Preliminary mass spectrometric analysis of synGAP in
the PSD fraction had revealed phosphorylation at Ser-773
within a motif recognized by CDK5 (data not shown). There-
fore, we tested whether purified CDK5 could phosphorylate
purified r-synGAP in vitro. Under the conditions of our assay
(Fig. 3A), phosphorylation of r-synGAP by CDK5 was approx-
imately linear with time for 10 min, after which r-synGAP con-
tained 0.3 to 0.4 mol of phosphate/mol. By 60 min, the stoi-
chiometry approached an asymptote of 1mol of phosphate/mol
of r-synGAP.
Phosphorylation of 0.3M r-synGAPbyCDK5/p35 occurred
at a similar rate (0.03 mol of phosphate/mol of substrate/min)
as phosphorylation of the CDK5 substrate histone H1 at a con-
centration of 4.3 M (data not shown). These results indicate
that r-synGAP is at least as good a substrate for CDK5 as his-
tone H1.
Identification of Sites in r-synGAP Phosphorylated by CDK5—
We used sensitive proteomic mass spectrometric methods to
identify all sites on r-synGAP phosphorylated by CDK5. r-syn-
GAP was incubated with CDK5/p35 for 2 or 10 min and
quenched with LDS stop buffer as described under “Experi-
mental Procedures.” Following separation by SDS-PAGE,
phosphorylated r-synGAPwas reduced, alkylated, and digested
in the gel with trypsin as described under “Experimental Proce-
dures.” Tryptic peptides were fractionated by nano-LC and
analyzed on a hybrid mass spectrometer equipped with a linear
ion trap in combination with Fourier transform ion cyclotron
resonance. Ions collected in the linear ion trapwere fragmented
by collision-induced dissociation (MS2) as described under
“Experimental Procedures.” If a neutral loss of 32.67, 49.00, or
97.97 Da was observed in MS2, an MS3 neutral loss scan was
acquired to detect the presence of dehydroalanine at phosphor-
ylation sites, resulting from the -elimination of H3PO4 from
phosphoserine. Following completion of data collection and
analysis via Mascot, as described under “Experimental Proce-
dures,” results were stringently filtered to a protein probability
of 99%, a two peptide minimum, and a peptide probability of
95% in Scaffold as described under “Experimental Procedures.”
The predicted false localization rate of phosphorylation site
TABLE 1
Intrinsic GAP activities of r-synGAP
Km and kcat values ofHRas, Rap1, andRap2, in the absence and presence of sr-synGAP and r-synGAP, are estimated fromdata in Fig. 2 fitted by nonlinear regression in Prism
as described under “Experimental Procedures.” Error is S.E. NF, could not be determined from fit.
GTPase Enzyme Km kcat
-Fold
stimulation
M s1
HRas GTPase alone 7.7 104 3 105
 sr-synGAP NF 0.13a 170a
 r-synGAP 640 400 0.12 0.05 150
Rap1 GTPase alone 1.1 104 1 105
 sr-synGAP 200 55 0.47 0.06 4300
 r-synGAP 1800 600 3.8 1.1 35,000
Rap2 GTPase alone 7.9 105 9 106
 sr-synGAP NF 0.82b 10,400b
 r-synGAP 3100 1500 6.8 3.0 87,000
a kobs, data observed at 700 M HRas.
b kobs, data observed at 400 M Rap.
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identifications was then assessed for each phosphopeptide
using theMascot Delta score as described previously (27). Pep-
tide sequence coverage of r-synGAP was in excess of 84%, with
90% coverage of the disordered domain (91.9% theoreticalmax-
imum coverage of r-synGAP calculated by ExPASy Peptide
Mass Program). We found no phosphorylated sites on r-syn-
GAP before it was incubated with CaMKII or CDK5.
We confirmed that Ser-773 and Ser-802 are phosphorylated
by CDK5, and we detected three additional sites (Ser-728, Thr-
775, and Ser-842) (Table 2 and supplemental data). Of the iden-
tified CDK5 phosphorylation sites, only Ser-773 and Ser-802
are located in a consensus motif for phosphorylation by CDK5
((S/T)P). Ser-773 is contained in a favored CDK5 consensus
sequence with a Lys at the 3 position (SPX(R/K)). Although
Ser-773 had a predicted phosphorylation false localization rate
of less than 1%, Ser-802 had a predicted rate greater than 5%
because it has a neighboring serine. However, close inspection
ofmass spectra frompeptides thatarepredicted tobephosphor-
ylated at Ser-802, and high mascot scores (65–85) for their
MS2 andMS3 spectra, confirmed the presence of phosphory-
lation at Ser-802. Because of its close proximity to Ser-773,
phosphorylation at Thr-775 may serve the same regulatory
function as Ser-773, and/or its phosphorylation may result
from promiscuity of the enzymatic phosphorylation. We
chose to focus our efforts on Ser-773 and Ser-802 because of
their localization within CDK5 consensus sequences and
their phosphorylation in synGAP within the PSD (see
below). However, we note that Ser-728 and Ser-842 may also
be legitimate CDK5 phosphorylation sites.
Stoichiometry and Rate of r-synGAP Phosphorylation by
CaMKII—In preparation for comparison of the effects of phos-
phorylation of r-synGAP by CDK5 and CaMKII, we examined
the time course of phosphorylation of r-synGAPbyCaMKII. As
we found previously for full-length synGAP (11), r-synGAP is
phosphorylated rapidly and to a high stoichiometry by CaMKII
(Fig. 3B). Themost rapid phosphorylation occurs within 2min,
after which r-synGAP contains6mol of phosphate/mol, indi-
cating that there are many phosphorylation sites recognized by
CaMKII. After 10 min, the rate reaches an asymptote at a stoi-
chiometry of 9 mol of phosphate/mol. Because our GAP
assays are inhibited by concentrations of ATP in excess of 30
M, we compared the stoichiometry of r-synGAP phosphory-
lation by CaMKII at 30 and 500 M ATP. Reaction mixtures
containing 30 M ATP followed the same reaction profile as
reactions with 500MATP; however, the overall stoichiometry
plateaued at 6.5 mol of phosphate incorporated per pmol of
r-synGAP (data not shown). The stoichiometry and time
course of phosphorylation of r-synGAP by CaMKII in 30 M
ATP were nearly identical to those of phosphorylation
FIGURE 3. Stoichiometry of phosphorylation of r-synGAP by CDK5 and
CaMKII. A, stoichiometry of phosphorylation by CDK5/p35. r-synGAP (286
nM) was incubated in the presence of CDK5/p35 (110 nM) and 500 M
[-32P]ATP (375 cpm/pmol), as described under “Experimental Procedures.”
At the indicated times, reactions were quenched by addition of 4 LDS sam-
ple buffer. Radiolabeled r-synGAP was isolated by SDS-PAGE on 4–12% gels
and visualizedwith a PhosphorImager as described under “Experimental Pro-
cedures.” Thecontentof labeledphosphate in the r-synGAPproteinbandwas
quantifiedwith the use of ImageQuant TL software. B, stoichiometry of r-syn-
GAP phosphorylation by CaMKII. r-synGAP (286 nM) was phosphorylated in
the presence of CaMKII (3.1 nM), 500 M [-32P]ATP (100 cpm/pmol), 0.7 mM
CaCl2, and 3.4M calmodulin (CaM) as described under “Experimental Proce-
dures.” Labeled synGAPwasquantified as described forA.C,phosphorylation
by CaMKII of individual sites on r-synGAP. r-synGAP (286 nM) was phosphor-
ylated as described in B, with cold ATP in place of [-32P]ATP. Following frac-
tionation by SDS-PAGE, r-synGAP was transferred to PVDF membranes and
probed with anti-phospho-synGAP-Ser-764/5 and anti-phospho-synGAP-
Ser-1123, as described under “Experimental Procedures.” Staining was quan-
tified on a Li-Cor imager as described under “Experimental Procedures.”
Intensity of staining for phosphorylated Ser-765 and Ser-1123 was normal-
ized for each to the value at 10 min. All data are mean S.E. (n 4).
TABLE 2
Identification of CDK5 phosphorylation sites in r-synGAP
Residues marked with an X are CDK5 phosphorylation sites in r-synGAP identified
as described under “Experimental Procedures.” Phosphorylated residues are cate-
gorized according to the length of the phosphorylation reaction (2 and 10 min) and
their detection in MS2 or MS3 spectra. The sites highlighted with an asterisk have
phosphorylation false localization rates less than 1% (predicted as described under
“Experimental Procedures”).
Residue
phosphorylated
2 min 10 min
MS2 MS3 MS2 MS3
Ser-728 X* X* X* X*
Ser-773 X* X* X* X*
Thr-775 X X X X
Ser-802 X X X X
Ser-842 X* X X
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reactions carried out with endogenous synGAP and CaMKII in
the PSD fraction (11).
Phosphorylation of r-synGAP by CaMKII (Fig. 3B) pro-
ceeded more rapidly and to a higher stoichiometry than phos-
phorylation by CDK5 (Fig. 3A), despite the fact that reaction
mixtures for CaMKII contained a 100:1 molar ratio of r-syn-
GAP (substrate) to kinase, whereas those for CDK5 contained a
2:1 molar ratio of r-synGAP to kinase.
To compare the rate of phosphorylation of two previously
identified sites on r-synGAP by CaMKII, we used phosphosite-
specific antibodies developed against phosphorylated peptides
containing Ser-765 and Ser-1123 (11).Wemeasured phosphor-
ylation of the two sites by Western blotting as described under
“Experimental Procedures” (Fig. 3C). Ser-1123 was phosphor-
ylated very rapidly, to70% of maximum in the first 2 min and
reaching a plateau by 10min. Ser-765was phosphorylatedmore
slowly at a linear rate reaching a maximum at 10 min.
Identification of Sites in r-synGAPPhosphorylated byCaMKII—
We identified all sites of phosphorylation of r-synGAPbyCaMKII
using the same sensitive proteomic mass spectrometric methods
described above.We confirmed the presence of sixCaMKII phos-
phorylation sites previously identified by our laboratory (Ser-751,
Ser-765, Ser-1093, Ser-1095, Ser-1099, andSer-1123) (Table 3 and
supplemental data). We also identified 10 additional phosphoryl-
ation sites in r-synGAP (Ser-737, Ser-821, Ser-825, Ser-827, Ser-
882, Ser-883,Thr-897, Ser-1150, Ser-1210, andSer-1283) (Table 3
and supplemental data). All of these sites were detected at both
the 2- and 10-min time points and had false localization rates
of less than 1%. Phosphorylation was detected at sites Ser-
750, Ser-756, and Ser-764, primarily at 10 min; however, the
phosphorylation false localization rates at these sites were
5%. Because sites Ser-737, Ser-751, Ser-765, Ser-1093, Ser-
1095, Ser-1099, Ser-1123, Ser-1150, Ser-1210, and Ser-1283
had false localization rates under 1%, we believe that these 10
serines are all candidates for sites of phosphorylation of
r-synGAP by CaMKII. We detected a large number of phos-
phorylation sites between residues 800 and 900 suggesting
that this regionmay be exposed to the protein surface and/or
particularly disordered. Either circumstance could lead to
promiscuous phosphorylation of serine and threonine resi-
dues in this region.
Effect of CDK5 Phosphorylation on GAP Activity of r-synGAP—
Wemeasured GAP activity of r-synGAP before and after phos-
phorylation by CDK5 for 1, 2, 5, and 10 min as described under
“Experimental Procedures” (Fig. 4, A–C). Phosphorylation by
CDK5 increased the HRas (Fig. 4A) GAP activity of r-synGAP
substantially (98%) and the Rap1 (Fig. 4B) GAP activity slightly
(20%), but it did not increase Rap2 GAP activity (Fig. 4C). The
effect of CDK5 on HRas reached significance after 2 min and
plateaued at 5 min. The effect on Rap1 was nearly maximal
(15%) after 1 min. These data show that phosphorylation of
r-synGAP by CDK5 accelerates its rate of inactivation of HRas
considerably more potently than its inactivation of Rap1.
Effect of CaMKII Phosphorylation on GAP Activity of r-synGAP—
Wemeasured GAP activity of r-synGAP before and after phos-
phorylation by CaMKII as described under “Experimental Pro-
cedures” (Fig. 4,D–F). In contrast toCDK5, phosphorylation by
CaMKII increased theHRas (Fig. 4D) GAP activity of r-synGAP
slightly (25%) and the Rap1 (Fig. 4E) GAP activity of r-synGAP
substantially (76%). Like CDK5, it did not increase its Rap2
GAP activity (Fig. 4F). CaMKII phosphorylation of r-synGAP
produced a gradual increase in Ras GAP activity, plateauing at
10 min. In contrast, Rap1 GAP activity increased to near its
maximum level after 1 min (61%) of phosphorylation by
CaMKII. Thus, phosphorylation of r-synGAPbyCaMKII accel-
erates its rate of inactivation of Rap1more potently than its rate
of inactivation of HRas.
Phosphorylation byCDK5orCaMKIIAlters the Ratio ofHRas
GAP and Rap1 GAP Activities of r-synGAP—The intrinsic rate
of hydrolysis of GTP by HRas (0.0004–0.0008 s1) (36) is
7–10 times faster than that of Rap1 (0.00005–0.0001 s1)
(37). However, unphosphorylated r-synGAP and endogenous
synGAP (5) stimulate Rap’s GTP hydrolysis much more
potently thanthatofRas (5,6). Inourexperiments,unphosphor-
ylated r-synGAP caused Rap1 to be inactivated at a rate 3.9
times faster than HRas (Fig. 5). Phosphorylation by CDK5 or
CaMKII shifts this ratio significantly. Phosphorylation by
CDK5 for 10 min decreases it to2.2 by preferentially increas-
ing stimulation of HRas GAP activity. Conversely, phosphory-
lation by CaMKII increases the ratio to 5.5 by preferentially
increasing stimulation of Rap1 GAP activity.
Regulation of GAP Activity of r-synGAPMutants—To deter-
minewhichCDK5phosphorylation sites are responsible for the
effects of phosphorylation on GAP activity, we created muta-
tions in r-synGAP at sites Ser-773 and Ser-802, as well as at
TABLE 3
Identification of CaMKII phosphorylation sites in r-synGAP
Residues marked with an X are CaMKII phosphorylation sites in r-synGAP identi-
fied as described under “Experimental Procedures.” Phosphorylated residues are
categorized according to the length of the phosphorylation reaction (2 and 10 min)
and detection in MS2 or MS3 spectra. The sites highlighted with an asterisk have
phosphorylation false localization rates less than 1% (predicted as described under
“Experimental Procedures”).
Residue
modified
2 min 10 min
MS2 MS3 MS2 MS3
Ser-728 X X
Ser-737 X* X* X* X*
Ser-750 X
Ser-751 X* X*
Ser-756 X
Ser-764 X
Ser-765 X* X* X* X*
Ser-808 X X
Ser-809 X X
Ser-810 X X
Ser-821 X* X*
Ser-825 X* X* X* X*
Ser-827 X* X* X* X*
Ser-842 X
Ser-843 X
Ser-882 X* X* X* X*
Ser-883 X* X* X*
Thr-885 X*
Ser-892 X*
Thr-897 X* X* X* X*
Thr-898 X X X
Ser-990 X X X
Ser-1093 X* X*
Ser-1095 X* X*
Ser-1099 X* X* X* X*
Ser-1123 X* X*
Ser-1150 X* X* X*
Ser-1171 X X X
Ser-1210 X* X* X* X*
Ser-1283 X* X* X* X*
Thr-1291 X*
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combinations of other phosphorylation sites. The sites were
mutated to alanine to prevent their phosphorylation (phospho-
deficient) or to aspartic acid to mimic the effect of phosphory-
lation by adding a negative charge (phosphomimetic). Mutants
were purified by the same procedure as wild type r-synGAP as
described under “Experimental Procedures.”
We first measured the HRas and Rap1 GAP activities of the
mutants (Fig. 6). As expected, mutations T775A and S802A did
not affect the GAP activity of r-synGAP. Unexpectedly, muta-
tion S773A and the double mutation S773A/T775A resulted in
significantly reduced stimulation of GAP activity compared
with the wild type construct. This effect was most pronounced
for Rap2GAP activity (Fig. 6C), least pronounced for Rap1GAP
activity (Fig. 6B), and intermediate for HRas GAP activity (Fig.
6A). In contrast, the triplemutation S773A/T775A/S802A pro-
duced an increase in HRas and Rap2 GAP activities (Fig. 6, A
FIGURE4.Effect of CDK5orCaMKII phosphorylationonGAPactivity of r-synGAP. r-synGAPwasphosphorylated for 1–10min in thepresenceof CDK5/p35
or CaMKII as describedunder “Experimental Procedures.” In thephosphorylation reactions, the synGAP, CDK5, andCaMKII concentrationswere 2.5, 2.1, and3.2
times higher, respectively, than in the reactions shown in Fig. 3. GAP activities of control and phosphorylated r-synGAP (250 nM) were then measured by
incubation with [-32P]GTP-loaded GTPases for 10 min at 25 °C as described under “Experimental Procedures.” A, HRas GAP activity; B, Rap1 GAP activity; and
C, Rap2 GAP activity following phosphorylation by CDK5. D, HRas GAP activity; E, Rap1 GAP activity; and F, Rap2 GAP activity following phosphorylation by
CaMKII. Initial rates were measured at 10 min; GTPase activity was linear for 25 min (data not shown). Data are mean  S.E. (A–C, n  10; D–F, n  9). The
statistical significance of differences from the GTPase activity of unphosphorylated r-synGAP (No Kinase) was determined by ordinary one-way ANOVA
(uncorrected Fisher’s LSD). **, p	 0.01; ***, p	 0.001; ****, p	 0.0001.Dotted lines indicate the levels of GTPase activity in the presence of unphosphorylated
synGAP.
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and C) and did not affect Rap1 GAP activity (Fig. 6B). These data
suggest that mutation of Ser-773 to alanine disrupts folding of
synGAP in away that reduces catalysis; however,mutation of Ser-
802 to alanine abrogates this effect and even stimulates catalysis.
These two phosphorylation sites flank a 6-residue polyproline
motif (Fig. 1C),which can forma relatively rigid rod-like structure.
It is possible thatmutation of serines, or their phosphorylation, on
either side of this motif have a particularly powerful effect on the
position of the disordered domain in relation to theGAP catalytic
domain and thus alter GAP activity.
The CTM-Plus mutant of r-synGAP, described under
“Experimental Procedures,” in which serines and threonines at
positions 750, 751, 756, 764, 765, 1058, 1062, 1064, 1093, 1095,
1099, 1123, and 1125 are all mutated to alanine, closely resem-
blesmutant S773A in its enzymatic behavior. This suggests that
bulk mutagenesis of serines and threonines to alanine in the
disordered domain alters protein folding in a way similar to the
mutation S773A.
Single and double phosphomimetic mutations S773D, T775D,
and S773D/T775D completely inhibited HRas and Rap2 GAP
activities, suggesting that phosphorylation of Ser-773 or Thr-
775 may be inhibitory. However, the inhibition of Rap1 GAP
activity by these mutations was small. In contrast, the S802D
mutant and the double mutant S773D/S802D increased all
three GAP activities above that of wild type, HRas (25%),
FIGURE 5. Alteration of the ratio of HRas GAP and Rap1 GAP activities
of r-synGAP after phosphorylation by CDK5 or CaMKII.Data from Fig. 4
are re-plotted to emphasize the change in ratio of HRas GAP and Rap1 GAP
activities after phosphorylation of r-synGAP for 10min by CDK5 or CaMKII.
The data for unphosphorylated r-synGAP from Fig. 4 were combined. The
numbers above each bracket are the ratios of the means of Rap1 GAP
activity to HRas GAP activity for each pair of conditions. Plotting the data
for HRas and Rap1 on the same axis emphasizes r-synGAP’s greater stim-
ulation of GTP hydrolysis by Rap1 compared with HRas. Note that, in the
absence of synGAP, Rap1 has a lower rate of GTP hydrolysis than HRas
(Table 1).
FIGURE 6. Intrinsic GAP activities of alanine and aspartic acid mutants of r-synGAP. GAP activities of wild type and mutant r-synGAP (250 nM) were
measured by incubation with [-32P]GTP-loaded GTPases for 10min at 25 °C as described under “Experimental Procedures.” A,HRas GAP activity; B, Rap1 GAP
activity; and C, Rap2 GAP activity. Proteins are named according to their specific point mutations (as described under “Experimental Procedures”). Initial rates
were measured at 10 min; GTPase activity was linear for 25 min (data not shown). Data are mean S.E. (n 5). The statistical significance of differences from
the GTPase activity of wild type r-synGAP (WT) was determined by ordinary one-way ANOVA (uncorrected Fisher’s LSD). *, p	 0.05; **, p	 0.01; ***, p	 0.001;
****, p	 0.0001. Dotted lines indicate the levels of GTPase activity in the presence of wild type synGAP.
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Rap1 (20%), and Rap2 (30 and 17%, respectively). This result
suggests that phosphorylation of Ser-802 may enhance GAP
activity.
When compared with Fig. 4, the data indicate that phospho-
mimetic mutants of r-synGAP at these three sites do not accu-
rately reproduce the effects of phosphorylation byCDK5.How-
ever, they do suggest that phosphorylation at Ser-773/Thr-775
might inhibit GAP activity of r-synGAP, whereas phosphory-
lation at Ser-802might increase it. They also suggest that phos-
phorylation of both sites at the same time would produce a net
increase in GAP activity.
We further tested this hypothesis by phosphorylating the
S773D r-synGAP mutant with CDK5. Before phosphorylation,
this mutant has no HRas GAP activity and reduced Rap1 GAP
activity.Wepredicted thatCDK5would phosphorylate Ser-802
in themutant and that this would increaseHRas and Rap1GAP
activities. As predicted, HRas GAP activity was increased by
220% and Rap1 GAP activity by 9% after phosphorylation (Fig.
7). In comparison, phosphorylation ofWT synGAPwith CDK5
increased HRas GAP activity 98% and Rap1 GAP activity 20%,
supporting the conclusion that phosphorylation of Ser-802may
account for a major portion of the differential regulation of
HRas and Rap GAP activities by CDK5.
We also predicted that phosphorylation of the S802Amutant
by CDK5 would result primarily in phosphorylation at Ser-773,
causing a decrease in HRas and Rap1 GAP activities, as we had
observed for the S773Dmutant. Again, as predicted, phosphor-
ylation of the S802Amutant with CDK5 caused a 61% decrease
in HRas GAP activity and a 9% decrease in Rap1 GAP activity,
supporting the inhibitory role of phosphorylation at Ser-773.
To determine whether additional, noncanonical CDK5
phosphorylation sites play a role in regulating GAP activity, we
phosphorylated the S773A/T775A/S802A triple mutant in the
presence of CDK5, which should cause phosphorylation at one
or both of the noncanonical sites, Ser-728 and Ser-842, which
had been detected by mass spectrometry (Table 2). The phos-
phorylation produced a 57% increase in HRas GAP activity and
no significant change in Rap1 GAP activity. These results sug-
gest that noncanonical phosphorylation sites do indeed play a
role in regulation of HRas GAP activity by CDK5. Theymay act
togetherwith Ser-802 to regulateHRas andRap1GAPactivities
by a combinatorial mechanism. An understanding of the struc-
tural basis of this complex regulation of GAP activity by phos-
phorylation of the disordered domain will require additional
structural studies.
Phosphorylation of Ser-773 and Ser-802 in the PSD Fraction
from Mouse Brain—To test whether CDK5 phosphorylates
synGAP in vivo in the PSD, we looked for phosphorylation of
Ser-773 and Ser-802 on endogenous synGAP in the PSD frac-
tion from mouse brain. We incubated mouse PSD fractions in
the absence and presence of Mg2/ATP, exogenous CDK5/
p35, and roscovitine, as described under “Experimental Proce-
dures”. Proteins were fractionated by SDS-PAGE, and the 140–
160-kDa bands containing synGAP were excised for tryptic
digestion. Coupled liquid chromatography and hybrid quadru-
pole-Orbitrap mass spectrometric analysis of the digests con-
firmed that Ser-773 and Ser-802 are phosphorylated in isolated
PSDswithout addition of exogenous kinase (Fig. 8,A andB) and
are phosphorylated concurrently when exogenous CDK5/p35
is added to the PSD (Fig. 8,C andD). Addition ofMg2/ATP to
the PSD did not significantly change the amount of phosphor-
ylation at either site; however, simultaneous addition of puri-
fied CDK5/p35 and Mg2/ATP increased the phosphorylation
of both sites substantially, indicating that both sites are acces-
sible to phosphorylation by CDK5 in the PSD. Addition of the
CDK5 inhibitor roscovitine with exogenous CDK5/p35 pre-
vented additional phosphorylation at both sites, indicating that
CDK5 is the primary kinase responsible for phosphorylation of
Ser-773 and Ser-802 in these experiments.
NMDA Receptor-dependent Activity Differentially Regulates
Phosphorylation of synGAP at Ser-773 (CDK5) and at Ser-765
and Ser-1123 (CaMKII)—We used a commercially available
antibody that recognizes CDK5 substrates phosphorylated on
FIGURE 7. Effect of CDK5 phosphorylation on the GAP activities of
selected alanine and aspartic acid mutants of r-synGAP. Wild type and
mutant r-synGAP were phosphorylated for 10 min in the presence of CDK5/
p35 as described in Fig. 4,A and B. Initial rates of GAP activities for control and
phosphorylated r-synGAP (250 nM) were then measured by incubation with
[-32P]GTP-loaded GTPases for 10 min at 25 °C. GTPase activity was linear for
25 min (data not shown). A, HRas GAP activity; and B, Rap1 GAP activity. Pro-
teins are named according to their specific point mutations as in Fig. 7. Data
aremean S.E. (n 6–7). The statistical significance of differences between
GTPase activity of unphosphorylated and phosphorylated r-synGAP was
determined by ordinary one-way ANOVA (uncorrected Fisher’s LSD). *, p 	
0.05; **, p	 0.01; ****, p	 0.0001.
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serine residues within a CDK5 consensus sequence to study
phosphorylation of synGAP by CDK5 in living neurons. We
found that it binds to a band of the size of synGAP on immu-
noblots of proteins from the PSD fraction and to r-synGAP
after phosphorylation by purified CDK5 (Fig. 9A). We also ver-
ified that the antibody binds to synGAP after its immunopre-
cipitation from a brain membrane fraction with an anti-syn-
GAP antibody, as described under “Experimental Procedures”
(Fig. 9B). The antibody was raised against an antigen matching
the consensus sequence SPX(R/K). It binds to phosphorylated
mutant synGAPs containing T775A or S802A, but it does not
bind to a phosphorylated mutant containing both S773A and
T775A, in which Ser-802 is available for phosphorylation (Fig.
9A). These data indicate that the antibody recognizes only
phosphorylated site Ser-773, which contains a lysine at position
3 in addition to proline at1. Ser-802 has a proline at1, but
it does not have a basic residue at3.We were unable to find a
commercial antibody that recognizes phosphorylated Ser-802.
Activation of NMDA receptors on cultured neurons allows
influx of Ca2 and activation of CaMKII. It has also been shown
previously to cause a transient activation of CDK5, followed by
down-regulation through degradation of the CDK5 activator
p35 (38). Furthermore, prolongedNMDAR activation activates
calpain, an activator of CDK5 (39, 40). Calcium influx through
NMDA receptors also activates Ras via the guanine nucleotide
exchange factor, RasGRF1, and can activate Rap1, possibly via
activation of Epac2 or CalDAGGEF1 (9, 41–45). Thus, it is
plausible that the relative levels of phosphorylation of synGAP
FIGURE 8. Detection of phosphorylation of synGAP in the PSD fraction at Ser-773 and Ser-802 by mass spectrometry. A, mouse PSD fraction was
analyzed with no treatment or after phosphorylation for 10 min in the absence and presence of exogenous CDK5/p35 and roscovitine as described under
“Experimental Procedures.” Tryptic peptides derived fromphosphorylated Ser-773 and Ser-802 on synGAPwere detected and subjected toMS/MS analysis on
anOrbitrap Fusion as described under “Experimental Procedures.” A, tryptic digests of synGAP in the isolated PSD fractionwithout addition of exogenous ATP
or kinaseswere scanned. AnHCDMS/MS spectrumof the phosphorylated peptide 771LP(pS)PTK776 (doubly charged precursor ionwithm/z 361.6779) displays
a series of y and y* ions (y ion with a neutral loss of phosphoric acid) indicating that Ser-773 is phosphorylated in the PSD fraction. The peaks form/z 150–650
are plotted as relative intensity of peak at m/z 442.2288. B, HCD MS/MS spectrum of the phosphorylated peptide 801S(pS)PAYCTSSSDITEPEQK818 (doubly
charged precursor ion withm/z 1033.9166), from the same PSD sample as in A, displays a series of b and y ions indicating that Ser-802 is phosphorylated. The
peaks form/z 200–1485 are plotted as relative intensity of peak atm/z 501.2652. C and D, quantification of synGAP phosphorylation at residues Ser-773 and
Ser-802 (D) was performed on tryptic peptides from the indicated reactions as described under “Experimental Procedures.” Amounts are represented as a
percentage change relative to the PSD sample before exposure to exogenous Mg2/ATP or kinases. Statistical significance was calculated using MSstats
utilizing the Benjamini and Hochberg method to produce corrected p values. *, p	 0.05; ***, p	 0.001; ****, p	 0.0001. Rosc, roscovitine.
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by CDK5 and CaMKII, regulated by NMDAR activity, might
have an important role in controlling the absolute level, ratio,
and duration of NMDAR-dependent Ras and Rap activities at
the synapse.
To investigate whether NMDAR activity can regulate phos-
phorylation of synGAP by CDK5, wemeasured the time course
of phosphorylation of Ser-773 following treatment of cultured
cortical neurons with 25 M NMDA for 15 s to 5 min. For
comparison, we also measured phosphorylation of the CaMKII
sites, Ser-765 and Ser-1123 (11). Their levels of phosphoryla-
tion were measured by immunoblotting neuronal extracts with
phospho-site-specific antibodies (11). We detected steady-
state phosphorylation of CDK5 sites and of the CaMKII sites in
neuronal cultures that were not treated with NMDA. After
treatment with 25 MNMDA, phosphorylation of Ser-765 was
elevated at 15 s and peaked at1 min, and it returned to base-
line at 5 min after addition of NMDA (Fig. 9C). As we showed
previously (9), phosphorylation at Ser-1123 following treat-
mentwithNMDAwas biphasic, increasing at 15 s, falling below
baseline after a 5-min treatment (Fig. 9C), and further below
baseline by 10 min (data not shown). In contrast, phosphoryla-
tion of the CDK5 site Ser-773 decreased steadily following
NMDAR activation (Fig. 9C). Thus, the three sites have distinct
patterns of regulation during NMDAR activation.
Calcineurin and Protein Phosphatase 2A Differentially Regu-
late Dephosphorylation of synGAP—To dissect the factors
influencing the dynamic phosphorylation patterns of the three
sites, we determined which phosphatase activities regulate
their phosphorylation at steady state and after NMDAR activa-
tion. We tested for involvement of three well known phospha-
tases, protein phosphatase 1 (PP1), protein phosphatase 2A
(PP2A), and calcineurin (CaN). We used cyclosporin A (CsA,
5 M) as a highly specific inhibitor of CaN and okadaic acid
(OKA, 1M) to inhibit both PP1 and PP2A. At the extracellular
concentration thatwe used (1M),OKA is amore potent inhib-
itor of PP2A (30). Finally, we used 0.5 M tautomycin, a PP1-
specific inhibitor, to differentiate between the actions of PP1
and PP2A. Tautomycin had little effect on any of the sites (data
not shown); therefore, it is likely thatmost of the effects ofOKA
resulted from inhibition of PP2A. The inhibitors were applied
to cultured cortical neurons for 30 min followed by application
of 25 MNMDA for 0, 0.25, 1, 3, or 5 min. We measured phos-
phorylation of each of the sites in cortical extracts as described
under “Experimental Procedures.”
Treatment of cortical cultures with 1 MOKA resulted in an
increase in phosphorylation of Ser-765 at steady state and dur-
ing the NMDA treatment, indicating that PP2A is involved in
maintaining the steady-state level of phosphorylation of Ser-
765 under our conditions (Fig. 10A). In contrast, 5 MCsA had
no effect on its phosphorylation either at steady state or tran-
siently following NMDA treatment, indicating that CaN does
not regulate Ser-765.
Treatment with 1 M OKA, had a small effect on phosphor-
ylation of Ser-1123 at early times after treatment with NMDA
(0.25 and 1 min) but no significant effect at steady state or at
later time points (5 min) (Fig. 10B). In contrast, treatment with
5MCsA increased phosphorylation of Ser-1123 at steady state
and also after NMDAR activation with the highest increases
occurring at the longer times. The data suggest that, in the
absence of inhibitors, NMDA treatment activates CaMKII,
FIGURE 9. Changes in phosphorylation of synGAP at Ser-773, Ser-765, and Ser-1123 following activation of NMDA receptors in cultured primary
neurons. A, commercial anti-CDK5 substrate antibody binds to bands corresponding to synGAP on immunoblots of the PSD fraction and to purified WT and
mutant (T775A and S802A) r-synGAP variants phosphorylated with CDK5/p35. The antibody does not bind to a phosphorylated mutant in which Ser-773 is
mutated to alanine. B, commercial antibody recognizes synGAP after it is immunoprecipitated from a brainmembrane fraction with an anti-synGAP antibody
as described under “Experimental Procedures.” In this experiment, anti-PSD-95 Abwas used as a positive control because synGAP binds to PSD-95. Anti-GluR2
Ab was used as a negative control to show that the immunoprecipitation was specific. PSD-95 was present in the immunoprecipitate and GluR2 was not, as
expected (data not shown). C, cultured cortical neurons were treatedwith 25MNMDA for 0.25, 1, 3, or 5min. Phosphorylation of synGAP at Ser-765, Ser-773,
and Ser-1123wasmeasured by immunoblot as described under “Experimental Procedures.”Dotted line, Ser-765, n 9–11 independent experiments;Dashed
line, Ser-1123, n  9–11 independent experiments; solid line, Ser-773, n  5–7 independent experiments. Levels of phosphoproteins were normalized to
intensities of staining for MAP-2. Significance was determined by one sample t test compared with 100%. *, p	 0.05; **, p	 0.01; ***, p	 0.001.
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leading to rapid phosphorylation of Ser-1123, and it also acti-
vates CaN, leading to slower dephosphorylation of Ser-1123.
The result is a peak of phosphorylation at 15 s, followed by a
gradual fall to below baseline at 5 min. Thus, in contrast to
Ser-765, CaN appears to be the primary phosphatase regulating
dephosphorylation of Ser-1123.
In contrast to the CaMKII sites, phosphorylation of the
CDK5 site Ser-773 slowly decreased during treatment with 25
MNMDA (Fig. 10C), suggesting that phosphatases play a role
in NMDA receptor-dependent regulation of this site. Indeed,
inhibition of CaN with 5 M CsA changed the response to a
small but significant increase in phosphorylation of Ser-773 at
all times other than steady state. These results mean that activa-
tion of CaN during treatment with NMDA is responsible for the
gradualdephosphorylationof synGAPatSer-773. Ithaspreviously
been shown that NMDA treatment can transiently (within 1min)
activate CDK5 activity in cultured neurons (24). Such an increase
canonly be seen inourdata after 1minofNMDAtreatment in the
presenceofCsA(Fig. 10C).Treatmentwith1MOKAalsocaused
an increase in phosphorylation at Ser-773 at steady state and at
early time points, indicating that PP2A dephosphorylates Ser-773
at steady state.
FIGURE10.Differential regulationofSer-773, Ser-765, andSer-1123bykinasesandphosphatases followingactivationofNMDAreceptors in cultured
primary neurons. To inhibit PP2Aor CaN, either okadaic acid (green,OKA, 1M) or cyclosporin A (red,CsA, 5M), respectively, were applied to cortical cultures
30min before addition of 25MNMDA for 0.25, 1, 3, or 5min, as described under “Experimental Procedures.” Control cultures (blue) were treated as in Fig. 9C.
Phosphorylation of synGAP at specific sites was measured by immunoblotting as described in Fig. 9C. We verified that the effects of OKA in this experiment
were a result of inhibition of PP2Abyperforming complementary experimentswith the PP1-specific inhibitor tautomycin, which had very little effect (data not
shown). A, phosphorylation at Ser-765was significantly increased at all time points (including steady state) in OKA-treated cultures comparedwith controls in
which no inhibitor was added. In contrast, treatment with CsA had no significant effect on phosphorylation at Ser-765. B, phosphorylation at Ser-1123 was
significantly increased at 1 and 3 min in OKA-treated cultures, and at all time points in CsA-treated cultures, compared with controls. C, phosphorylation of
Ser-773was increased at all time points in the presence of CsA, peaking at 1min; treatment with OKA increased phosphorylation at steady state and from 15 s
to 3 min after NMDA treatment, compared with control. Significance in A–Cwas determined by t test, n 3–5 independent experiments. D, left, steady-state
level of phosphorylation of Ser-773 in cortical cultures is regulated, in part, by CDK5 and PP2A. Cortical cultures were treated with 1 M OKA for 30 min in the
absence or presence of 30M roscovitine, whichwas added 5min before OKA to block CDK5 prior to inhibition of PP2A. OKA alone increased the steady-state
level of phosphorylation of Ser-773 2.3-fold. Addition of roscovitine resulted in a significantly smaller increase, supporting the conclusion that CDK5
phosphorylates Ser-773 in neurons independently of treatment with NMDA (OKA/vehicle (veh): 231 18%, OKA/roscovitine (Ros): 183 4%). Pretreatment
with100M roscovitine for 30mindidnot further decrease thephosphorylationof Ser-773 (datanot shown). Significancewasdeterminedbyone-sample t test
compared with 100% and by t test, n  3–5 independent experiments. Right, transient change in phosphorylation of Ser-773 during activation of NMDA
receptors is regulated by CDK5 and CaN. Cortical cultures were treated with NMDA in the absence or presence of 5 M CsA for 30 min and in the absence or
presence of 100 M roscovitine, which was added 30 min before CsA to block CDK5 prior to inhibition of CaN. Addition of NMDA decreased phosphorylation
of Ser-773 to 75% of control in the absence of CsA or roscovitine. The presence of CsA during the treatment with NMDA increased phosphorylation of Ser-773
1.5-fold. This effect of CsA was almost completely blocked by simultaneous treatment with roscovitine. Vehicle, 74  6%; CsA/vehicle, 121  2%; CsA/
roscovitine, 92 7%. Significance was determined by ANOVAwith post hoc Tukey-Kramermultiple comparisons test, n 3 independent experiments. *, p	
0.05; **, p	 0.01; ***, p	 0.001.
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To confirm involvement of CDK5 in the dynamic regulation
of phosphorylation of Ser-773, we performed similar experi-
ments in which we incubated neurons with OKA or with OKA
and roscovitine, a specific inhibitor of CDK5 (46). The increase
in steady-state phosphorylation of Ser-773 in OKA was signif-
icantly reduced, although not back to control levels, by pre-
treatment with 30 M roscovitine (Fig. 10D), verifying that at
least a portion of phosphorylation of Ser-773 at steady state is
due to CDK5 activity. Pretreatment with a higher concentra-
tion of roscovitine (100 M) did not further decrease the phos-
phorylation (data not shown), suggesting that another kinase
(such as GSK3) may also phosphorylate Ser-773 in neurons.
We also confirmed the involvement of CDK5 in the increased
phosphorylation of Ser-773 at 1 min after activation of NMDA
receptors in the presence ofCsA (Fig. 10C).We treated neurons
with 5MCsA alone orwithCsAplus 100M roscovitine for 30
min and then applied 25 M NMDA for 1 min. The increase in
phosphorylation of Ser-773 in the presence of CsA is signifi-
cantly reduced by pretreatment with 100 M roscovitine (Fig.
10D). This result means that phosphorylation of Ser-773 by
CDK5 is stimulated by activation of NMDA receptors, and
CDK5 accounts for most of the increase in phosphorylation of
Ser-773 observed when CaN is inhibited.
DISCUSSION
Biological Role of synGAP—Mutations in synGAP1 are a
major cause of nonsyndromic cognitive disability in humans
and are particularly common (8–10%) in patients with associ-
ated epilepsy or autism (8, 47, 48). Most of the pathogenic
mutations characterized to date cause haploinsufficiency. In
mice, heterozygous deletion of synGAP, which produces hap-
loinsufficiency, leads to precocious spine formation during
development (49, 50), disruption of synaptic plasticity and
learning (7, 9), and an increased level of surface AMPA recep-
tors in neurons (51). The deleterious effects of loss of just one
copy of synGAP suggest that its functions are rate-limiting for
processes that are essential for normal synaptic function.
synGAP accelerates inactivation of the small GTPases Ras
and Rap (1, 2, 5, 6). These twoGTPases are central regulators in
dendrites; in particular, they contribute to regulation of exocy-
tosis and endocytosis of AMPA receptors near the synapse
(10). A prolonged increase in active Ras in neurons leads to
increased AMPAR exocytosis and thus to an increase in total
surface AMPA receptors, whereas prolonged activation of Rap
causes an increase in AMPAR endocytosis and a decrease in
surface AMPA receptors. The steady-state levels of activity of
the two GTPases are set by the balance of production of the
active forms by exchange of GDP for GTP and inactivation by
GTP hydrolysis. Unphosphorylated synGAP catalyzes inactiva-
tion of Rapmuchmore potently than inactivation of Ras (Fig. 2)
(6). Thus, its presencewould be expected to reduce endocytosis
of AMPA receptors relative to their exocytosis by decreasing
the steady-state level of active Rap to a greater extent than the
steady-state level of active Ras.
Physiological Role of Changes in the Relative Levels of Ras and
Rap GAP Activity of synGAP—Here, we have shown that phos-
phorylation of synGAP by CaMKII increases its ratio of Rap1
GAP to HRas GAP activities. We predict that, in neurons, this
would shift the steady-state balance of AMPAR trafficking near
the synapse toward exocytosis by decreasing the level of active
Rap1 more than active HRas. The net result would be an
increase in surface AMPA receptors. Conversely, phosphory-
lation of r-synGAP by CDK5 decreases its ratio of Rap1 GAP to
HRas GAP activities. We predict that this would shift the bal-
ance of trafficking near the synapse toward endocytosis of
AMPA receptors and lead to a decrease in the number of sur-
face AMPA receptors. Thus, phosphorylation of synGAP could
act like a rheostat to create transient changes in the number of
surface AMPA receptors or to gradually adjust their steady-
state level.
Although r-synGAP increases Rap2 GAP activity, this activ-
ity is not altered by any of the phosphorylation events reported
here. Both Rap1 and Rap2 are found in pyramidal neurons in
the hippocampus and cortex (Allen Mouse Brain Atlas); but,
the differences in their functions are not yet clear. There is a
precedent for differential regulation of the two forms of Rap. It
has been reported that the rasGEF family of proteins catalyze
nucleotide exchange for Rap2 but not for Rap1 (52).
Potential Role of Phosphorylation by CaMKII—CaMKII is
concentrated in spines and in the PSD (53). It is an early target
of Ca2/calmodulin that is formed in the spine when Ca2
flows throughNMDAreceptors (45).ActiveCaMKIIphosphor-
ylates Ser-1123 on synGAP at a rapid rate, nearly maximally
after 2 min in our assay (Fig. 3C). The increase in Rap1 GAP
activity of synGAP is also maximal after 2 min of phosphoryla-
tion (Fig. 4E), suggesting that it is produced by phosphorylation
of Ser-1123 or of another rapidly phosphorylated site. We pre-
dict that this rapid increase in Rap1 GAP activity would cause a
rapid decrease in active Rap1, leading to a relatively rapid
decrease in AMPAR endocytosis. The result would be an
increase in surface AMPA receptors.
In neurons, we have shown that activation of NMDA recep-
tors produces a rapid increase in phosphorylation of Ser-1123,
followed by a slower decrease in phosphorylation mediated by
the Ca2/calmodulin-dependent phosphatase, CaN (Figs. 9C
and 10B). Thus, we predict that the level of active Rap1 would
be decreased transiently relative to active HRas, producing a
transient increase in the rate of exocytosis of AMPA receptors
near the synapse. This rate would decrease gradually as CaN
dephosphorylates Ser-1123 and brings the rate of inactivation
of Rap1 back down.
It is well established that activation of CaMKII in the spine
triggers an increase in synaptic strength produced by enhanced
trapping of surface AMPA receptors at the postsynaptic site
(45, 54). A slightly slower increase in insertion of surfaceAMPA
receptors near the synapse has been observed after induction of
long term potentiation (55). We suggest that phosphorylation
of synGAP by CaMKII helps to mediate this transient increase
in AMPAR exocytosis.
Potential Role of Phosphorylation by CDK5—In contrast to
CaMKII, CDK5 activity is not regulated directly by Ca2 influx
or by synaptic activity. Instead, its catalytic subunit is activated
by binding to either of two small subunits termed p35 and p39
(14). The p35 and p39 subunits are degraded constitutively;
thus, the cellular level of CDK5 activity is maintained by syn-
thesis of the catalytic and regulatory subunits, which are
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induced by growth factors, including NGF and BDNF (14).
CDK5 is essential for normal brain development and function,
but its regulatory roles are generally homeostatic, in contrast to
the many transient and activity-dependent regulatory roles of
CaMKII (56).
The rate of phosphorylation of synGAP by CDK5 is consid-
erably slower than the rate of phosphorylation by CaMKII (Fig.
3, A and B). A relatively slow catalytic rate has also been
observed for CDK5 with other important neuronal substrates
(16). The absence of rapid activation mechanisms and its rela-
tively slow catalytic rate are consistent with a homeostatic role.
We postulate that phosphorylation of synGAP by CDK5 may
contribute to the homeostatic down-regulation of surface
AMPA receptors termed synaptic scaling (57). The mecha-
nisms that contribute to synaptic scaling are complex. Several
mechanisms act in parallel to tightly couple the rate of neuronal
activity to the total level of surface synaptic AMPA receptors in
neurons (57). CDK5 and polo-like kinase 2 (PLK2) have been
shown to be necessary for homeostatic reduction of surface
AMPA receptors following elevated neuronal activity (58). The
two kinases act in concert to phosphorylate spine-associated
Rap-specific GAP protein (SPAR), a constitutive synaptic Rap
GAP, and tag it for degradation. Loss of SPAR activity increases
the steady-state level of active Rap, thus increasing endocytosis
of surface AMPA receptors. Our results suggest that CDK5
phosphorylation can also decrease the level of surface AMPA
receptors by selectively increasing the Ras GAP activity of syn-
GAP, leading to a reduction of AMPAR exocytosis.
Regulation of synGAP by CDK5 appears to bemore complex
than its regulation by CaMKII.We have found that two sites on
synGAP, Ser-773 and Ser-802, are phosphorylated in isolated
PSDs and are phosphorylated concurrently when exogenous
CDK5 is added to PSDs (Fig. 8). However, mutations of these
two sites suggest that the functional effects of their phosphor-
ylation are quite different (Figs. 6 and 7). Mutations of Ser-773
to alanine (phospho-deficient) or to aspartic acid (phospho-
mimetic) inhibit HRas GAP and Rap2 GAP activities substan-
tially, and Rap1 GAP activity slightly. This finding means that
Ser-773 is crucial for GAP activity itself. In contrast, mutation
of Ser-802 to alanine has no effect on GAP activity, although
mutation to aspartic acid increases all GAP activities and over-
rides the effects of mutation of Ser-773. It is interesting that
these two sites are located on opposite sides of a 6-residue poly-
proline motif (Fig. 1C) that can form a relatively stiff rod along
the protein backbone. It is possible that residues on either side
of the polyproline motif play an important role in positioning
the downstream portion of the predicted disordered domain
with respect to the catalytic domains of synGAP.
We identified a phospho-specific antibody that allowed us to
monitor phosphorylation of Ser-773 in cultured neurons;
unfortunately, we were unable to monitor phosphorylation of
Ser-802. We found that activation of NMDA receptors in cul-
tured neurons triggers slow dephosphorylation of Ser-773
mediated by CaN (Figs. 9C and 10C). If Ser-802 is also dephos-
phorylated by CaN, this would reduce HRas GAP activity and
help to shift the balance of Ras andRap activity in favor of active
Ras, consistent with our rheostat hypothesis. However, confir-
mation of the role of Ser-802 will await new reagents or
methods.
The large number of serine and threonine phosphorylation
sites that we identified for CDK5 (at least 5) and CaMKII (at
least 10) are located in clusters within the predicted disordered
domain of synGAP (see Fig. 1C). This finding is consistent with
the proposal of Holt et al. and Collins (59, 60) that regulation of
protein function by serine/threonine phosphorylation often
depends on relatively nonspecific mechanisms that alter pro-
tein-protein interactions. These authors found that phosphor-
ylation sites in yeast proteins regulated by CDK1 are often
located in clusters that shift position in rapidly evolving disor-
dered domains. We have focused on the functions of two sites
phosphorylated by CDK5 (Ser-773 and Ser-802) that are
located next to proline residues. However, it is possible, per-
haps even likely, that the other three sites can also influence
regulatory interactions of the disordered domain with the Ras
GAPdomain. This possibility is supported by the finding shown
in Fig. 7A that phosphorylation of sites Ser-728 and Ser-842 can
contribute to an increase in HRas GAP activity in addition to
phosphorylation of Ser-802.
Significance of Differential Patterns of in Vivo Regulation of
Phosphorylation Sites on synGAP—The distinct patterns of reg-
ulation of the three phosphorylation sites, Ser-765, Ser-802,
and Ser-1123, during synchronous activation of NMDA recep-
tors is striking (Fig. 9C). The patterns arise from differential
regulation of each site by phosphatases and by kinases (Fig. 10).
This precise regulation lends credence to the importance of
synGAP inmediating activity-dependent and homeostatic syn-
aptic plasticity.
In summary, phosphorylation of r-synGAP by CaMKII and
CDK5 has opposite effects on the ratio of Rap1 GAP and HRas
GAP activities of synGAP. We postulate that phosphorylation
of synGAP by these two kinases contributes to regulation of the
number of surface AMPA receptors in and near spines during
synaptic potentiation (CaMKII) and during synaptic scaling
(CDK5).
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